Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for pain, nausea and vomiting after orthognathic surgery
IRCT20150613022697N9Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of dexmedetomidine in acute postoperative pain and postoperative nausea and vomiting (PONV), sponsored by Mashhad University of Medical Sciences. Primary endpoints: Postoperative pain intensity, Postoperative nausea and 1 more. Started Oct 2020; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
acute postoperative painpostoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on IRCT20150613022697N9.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20150613022697N9.